Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
03/2002
03/20/2002CN1081073C Medical liquid oxygen charging method and instrument
03/20/2002CN1081064C Medicine for treating diarrhea
03/20/2002CN1081061C Medicinal pill for treating piles
03/20/2002CN1081059C Medicinal capsule for treating stomach-ache
03/20/2002CN1081057C Chinese medicine composition for treating oral disease and preparing method thereof
03/20/2002CN1081055C Medicinal liquor for treating and fistula
03/20/2002CN1081053C External use medicinal ointment for curing prolapse of lumbar intervertebral disc and preparing process thereof
03/20/2002CN1081052C Fast-acting piles-treating Chinese medicine preparation
03/20/2002CN1081046C Medicinal decoction for treating diabets and its preparing process
03/20/2002CN1081044C Medicine for treating cancer and preparing process thereof
03/20/2002CN1081002C Fermented milks, enriched with iron and processes for producing same
03/19/2002US6359002 Method for treating a patient with neoplasia by treatment with a platinum coordination complex
03/19/2002US6358967 Ergoline amine derivatives with blood pressure lowering effect
03/19/2002US6358539 To supplement collagen and elastic tissues and thicken the dermis to reduce or eliminate the appearance of cellulite
03/19/2002US6358536 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal
03/19/2002US6358526 Forming a compactable granular mixture comprising compaction enhancing therapeutic compound that is different from compaction enhancing therapeutic compound and non-aesthetic excipients; compressing the granular mixture to form tablets
03/19/2002CA2128078C Nutritional product for trauma and surgery patients
03/14/2002WO2002020653A2 Antimicrobial adhesive latexes, methods of making thereof, and carpet articles containing same
03/14/2002WO2002020027A1 Transplatinum complexes as cytotoxic and anticancer agents
03/14/2002WO2002020026A2 Treatment of drug resistant organisms with nitric oxide
03/14/2002WO2002020025A1 Helium-oxygen mixture with therapeutic application
03/14/2002WO2002019970A1 Therapeutic topical solution for skin and associated methods of use
03/14/2002WO2002019961A2 Pharmaceutical compositions for headache, migraine, nausea and emesis
03/14/2002WO2001058918A3 Oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments
03/14/2002WO2000065028A9 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
03/14/2002US20020032464 Adhesion prevention and an endoscopic insufflation system therefor
03/14/2002US20020032234 First fatty acid compound that is a linoleic or linolenic compound and a second fatty acid that is a docosahexaenoic acid compound, an omega-3 or an omega-2 fatty acid or derivative
03/14/2002US20020032190 Contacting host with a cephalotaxine and an antiproliferative agent such as an alkylating agent, an intercalating agent, a metal coordination complex, a nucleoside, a nucleic acid enyme or protein inhibitor to modulate cell proliferation
03/14/2002US20020032182 Administering therapeutically effective amount of chromium in a pharmaceutically acceptable form to a patient for relieving secondary hypersomnia or secondary insomnia in the patient
03/14/2002US20020032179 Inhibiting the hyperproliferation of malignant or neoplastic cells by treating the cells with an antiproliferative amount of 1 alpha ,24(S)-dihydroxyvitamin D2 the cells being cancers of the lung, neck and head, pancreas, endometrium, bladder
03/14/2002US20020032169 Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue
03/14/2002US20020032151 Using an agent which promotes tyrosine protein dephosphorylation in the preparation of a medicament for reducing permeability of a physiological barrier such as the blood-brain barrier
03/14/2002US20020031557 Ascorbic acid composition and method for treatment of aging or damaged skin
03/14/2002US20020031556 Mixture of acid, tin pyrophosphate, salicylic acid and glycerides
03/14/2002US20020031555 Mixture of sodium (bi)carbonate and trisodium phosphate
03/14/2002US20020031535 Copper, copper sulfate, sodium carbonate, turpentine, ethanol, and water
03/14/2002US20020031505 Antitumor compositions containing taxane derivatives
03/14/2002CA2419403A1 Antimicrobial adhesive latexes, methods of making thereof, and carpet articles containing same
03/13/2002EP1185273A1 Antifungal oral composition containing itraconazole and process for preparing same
03/13/2002EP1185260A1 Ascorbic acid composition and method for treatment of aging or damaged skin
03/13/2002EP1185247A1 Anti-inflammatory bioactive glass particulates
03/13/2002EP1185243A1 An anti-microbial silicone rubber composition and method making said composition
03/13/2002EP1185242A1 An anti-microbial body care product
03/13/2002EP1154690A4 Composition for generating chlorine dioxide
03/13/2002EP1132090A4 Method for producing an agent for treating non-cancerous pathologies of the organism
03/13/2002CN1339968A Preparation for regulating lower bowel function
03/13/2002CN1339313A Pure traditional Chinese medicine for relaxing muscles and tendons and promoting blood circulation
03/13/2002CN1080574C Yuchuang ointment for treating sore
03/13/2002CN1080565C External-use capsule for curing woman diseases
03/12/2002US6355661 Methods for treatment of sickle cell anemia
03/12/2002US6355628 Combination therapy using pentafluorobenzenesulfonamides
03/12/2002US6355609 Methods for stabilizing liquid nutritional products and products so stabilized
03/12/2002US6355278 Dry dairy cow supplement
03/12/2002US6355275 Delivering an embolic agent formulation to a blood vessel to fill or plug the blood vessel and/or encourage clot formation so that blood flow through the vessel is reduced or ceases
03/12/2002US6355258 Method for formulating spill resistant pharmaceutical compositions in semi-solid form
03/07/2002WO2002018699A1 A nanometre-silver, long-acting, broad spectrum, antimicrobial, mouldproof granule and its producing methods
03/07/2002WO2002018440A1 Anti-angiogenic peptides
03/07/2002WO2002017966A1 Antacid chewing gum products coated with high viscosity materials
03/07/2002WO2002017933A1 Trace elements
03/07/2002WO2002017909A1 A therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives
03/07/2002WO2002017906A1 Composition and method for treatment of hypertriglyceridemia
03/07/2002WO2002017852A2 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
03/07/2002WO2002017735A2 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate
03/07/2002WO2001097750A3 Method for producing an antiviral agent
03/07/2002WO2001064226A3 Farnesyl protein transferase inhibitor combinations with platinum compounds
03/07/2002WO2001051040B1 Osmotic device containing alprazolam and an antipsychotic agent
03/07/2002WO2001041651A3 Microdermabrasion device
03/07/2002US20020028830 Treating proteinuria and swollen lymph node symptoms by administering an effective dose of a vitamin D analog to a patient on a diet which includes a calcium intake level of >800mg/day per 160 pound patient
03/07/2002US20020028796 Adjustment mineral concentration
03/07/2002US20020028775 Using mixture of flavonoids, cytochrome inhibitor, sugar, phosphate in carrier
03/07/2002US20020028769 Method for preparing zinc-oligopeptide easily absorbable by the human body
03/07/2002US20020028361 Substrate with a photocatalytic coating
03/07/2002US20020028254 Topically administering manganese and/or at least one organic and/or inorganic salt thereof.
03/07/2002US20020028253 Anti-cancer therapy agent of arsenic hexoxide (As4O6) of a natural chemical substance and its pharmaceutical composition
03/07/2002US20020027079 Electrolyzed water of anode side and process for production thereof
03/07/2002CA2420835A1 Composition and method for treatment of hypertriglyceridemia
03/07/2002CA2420765A1 Anti-angiogenic peptides
03/07/2002CA2419480A1 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
03/07/2002CA2382687A1 A therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives
03/06/2002EP1183234A1 INHIBITORS OF FACTOR Xa
03/06/2002CN2479952Y Nm silver plaster for trauma
03/06/2002CN1338952A Cartridge for dialysis containing sodium bicarbonate
03/06/2002CN1338316A Anticoagulating displacement liquid for extracorporeal circulation of blood
03/06/2002CN1338299A Chinese medicine for treating bone fracture
03/06/2002CN1338292A Liquid medicine for treating burn and scald
03/06/2002CN1338290A Ointment for treating burn
03/06/2002CN1338282A Bone-setting medicine and its preparing process
03/06/2002CN1338274A Powdered medicine 'Shaotangsan' for treating burn and scald
03/06/2002CN1338260A Medicine for treating cancers
03/06/2002CN1080125C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
03/06/2002CN1080116C Use of medicinal feed for systemic treatment of fish diseases
03/05/2002US6353031 Bathing composition for analgesics
03/05/2002US6352724 Method for treating acne and/or rosacea
03/05/2002US6352714 Method of producing a metal nutrient for an animal feed
03/05/2002US6352713 Chewable, non-acidic prenatal tablet containing vitamin c derivative, folic acid, flavor, and glycyrrizin sweetener; gastrointestinal side effect reduction; no tooth enamel erosion
03/05/2002US6352711 Mucoadhesive comprising microbiocide, dexamethasone, and diphenhydramine; analgesic, antihistamine, and antiinflammatory agents; secondary infection prevention
03/05/2002US6352709 Introducing into patient a medical device of which at least a portion comprises one of a sydnonimine and a furoxan; anticoagulants
03/05/2002CA2051531C Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition
02/2002
02/28/2002WO2002015895A2 Alpha-difluoromethylornithine (dfmo) use in the human prostate
02/28/2002WO2002015881A2 Use of a porous carrier